Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 57Recruiting 15Terminated 10Active not recruiting 5Unknown 4Withdrawn 1Suspended 1Not yet recruiting 1Approved for marketing 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Specimen Handling 8venetoclax 7Azacitidine 6Cyclophosphamide 5Biopsy 4fludarabine phosphate 3Tacrolimus 3Etoposide 3fludarabine 2Stem Cell Transplantation 2Mitoxantrone 2Melphalan 2Magnetic Resonance Spectroscopy 2Cytarabine 2vactosertib 1regorafenib 1prednylidene 1methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside Pt(II) 1iadademstat 1gilteritinib 1eltrombopag 1deltacortene 1decitabine and cedazuridine drug combination 1cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV)) 1brincidofovir 1beta-apocarotenoid-14',13'-dioxygenase 1azathiopurine 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1aldesleukin 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Gemtuzumab × Other hematologic neoplasm × Clear all
NCT05955261 2026-04-23

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

St. Jude Children's Research Hospital

Phase 2 Suspended
70 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡